FDA official logo
GSRS logo
PFDA official logo

INSULIN DETEMIR

  • UNII: 4FT78T86XV
  • Preferred Substance Name: INSULIN DETEMIR

  • 169148-63-4
  • (1A-21A),(1B-29B)-INSULIN (HUMAN), 29B-(N6-(1-OXOTETRADECYL)-L-LYSINE)-, RECOMBINANT
  • 29(SUP B)-(N(SUP 6)-(1-OXOTETRADECYL)-L-LYSINE)-(1(SUP A)-21(SUP A)),(1(SUP B)-29(SUP B))-INSULIN (HUMAN)
  • 29(SUP B)-(N(SUP 6)-MYRISTOYL-L-LYSINE)-30(SUP B)-DE-L-THREONINEINSULIN (HUMAN)
  • DETEMIR
  • INSULIN B29(N-MYRISTOYL-LYS)-B30(DES-THR) HUMAN RECOMBINANT
  • INSULIN DETEMIR [EMA EPAR]
  • INSULIN DETEMIR [INN]
  • INSULIN DETEMIR [MI]
  • INSULIN DETEMIR [USAN]
  • INSULIN DETEMIR [WHO-DD]
  • INSULIN DETEMIR RECOMBINANT
  • INSULIN DETEMIR RECOMBINANT [ORANGE BOOK]
  • INSULIN,DETEMIR,HUMAN
  • INSULIN,DETEMIR,HUMAN [VANDF]
  • LEVEMIR
  • N.EPSILON.B29-TETRADECANOYL DES(B30) HUMAN INSULIN
  • NN-304

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.